Treatment of HIV infection and its complications.
Because the AIDS epidemic continues to grow, there is a sense of urgency to develop new treatment strategies, both for HIV infection and for AIDS-related illnesses. The rapid gathering of basic information related to HIV type 1 biology and opportunistic infections has led to an explosion in physicians' ability to diagnose, prevent, and treat HIV disease and its associated complications. Research in this rapidly evolving field is likely to lead to further advances in the months and years that follow.
Polsky
B
B
Infectious Disease Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy; D009181:Mycoses / Q000188:drug therapy; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy; D011480:Protease Inhibitors / Q000627:therapeutic use; D012514:Sarcoma, Kaposi / Q000188:drug therapy
D019380:Anti-HIV Agents; D000998:Antiviral Agents; D011480:Protease Inhibitors